Somatostatin increases mitogen-induced IL-2 secretion and proliferation of human Jurkat T cells via sst3 receptor isotype

Journal of Cellular Biochemistry

Volumn 68, Issue 1, 1998, Pages 62-73

  Cardoso, Alicia ^a   El Ghamrawy, Christelle ^a   Gautron, Jean Pierre ^b   Horvat, Branka ^a   Gautier, Nicole ^c   Enjalbert, Alain ^b   Krantic, Slavica ^a,d  

^a Univ Claude Bernard   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c UNIVERSITÉ LYON 1   (France)

^d CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Adenylyl cyclase; Interleukin 2 (IL 2); Jurkat cells; Proliferation; Receptor isotypes; Somatostatin

Indexed keywords

ADENYLATE CYCLASE; INTERLEUKIN 2; MESSENGER RNA; MITOGENIC AGENT; PHORBOL ESTER; PHYTOHEMAGGLUTININ; SOMATOSTATIN; SOMATOSTATIN RECEPTOR;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 14444267311     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19980101)68:1<62::AID-JCB6>3.0.CO;2-U     Document Type: Article

References (43)

1. Aguila MC, Dees WL, Haensly WE, McCann SM (1991): Evidence that somatostatin is localized and synthesized in lymphoid organs. Proc Natl Acad Sci USA 88:11485-11489.
2. Azad N, LaPaglia N, Kirsteins L, Uddin S, Steiner J, Williams DW, Lawrence AM, Emanuele NV (1997): Jurkat cell proliferative activity is increased by luteinizing hormone-releasing hormone. J Endocrinol 153:241-249.
3. Beaudet A, Greenspun D, Realson J, Tannenbaum GS (1995): Patterns of expression of SSTR1 and SSTR2 somatostatin receptor subtypes in the hypothalamus of the adult rat: relationship to neuroendocrine function. Neuroscience 65:551-561.
4. Bhathena SJ, Louie J, Schechter GP, Redman RS, Wahl L, Recant L (1981): Identification of human mononuclear leucocytes bearing receptors for somatostatin and glucagon. Diabetes 30:127-131.
5. Blum AM, Metwali A, Mathew RC, Cook G, Elliott D, Weinstock JV (1992): Granuloma T lymphocytes in murine schistosomiasis mansoni have somatostatin receptors and respond to somatostatin with decreased IFNγ secretion. J Immunol 149:3621-3626.
6. Boudard F, Bastide M (1991): Inhibition of mouse T cell proliferation by CGRP and VIP: Effects of these neuropeptides on IL-2 production and cAMP synthesis. J Neurosci Res 29:29-41.
7. Bruno JF, Xu Y, Song J, Berelowitz M (1993): Tissue distribution of somatostatin receptor subtype messenger ribonucleic acid in the rat. Endocrinology 133:2561-2567.
8. Calvo CF, Chavanel G, Senik A (1992): Substance P enhances IL2 expression in activated human T cells. J Immunol 148:3498-3504.
9. Elliott DE, Metwali A, Blum AM, Sandor M, Lynch R, Weinstock JV (1994): T lymphocytes isolated from the hepatic granulomas of schistosome-infected mice express somatostatin receptor subtype II (SSTR2) messenger RNA. J Immunol 153:1180-1186.
10. Elliott L, Brooks W, Roszman T (1992): Inhibition of anti-CD3 monoclonal antibody-induced T-cell proliferation by dexamethasone, isoproterenol, or prostaglandin E2 either alone or in combination. Cell Mol Neurobiol 12:411-427.
11. Enjalbert A, Sladeczek P, Guillon G, Bertrand P, Shu C, Epelbaum J, Garcia-Sainz JA, Jard S, Lombard S, Kordon C, Bockaert J (1986): Angiotensin II and dopamin modulate both cAMP and inositolphosphate production in anterior pituitary cells. Involvement in prolactin secretion. J Biol Chem 261:4071-4079.
12. Feiten DL, Feiten SY, Carlson SL, Olschowska JA, Livnat S (1985): Noradrenergic and peptidergic innervation of lymphoid tissue. J Immunol 135:755s-765s.
13. Frohman MA, Dusch M, Martin GR (1988): Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer. Proc Natl Acad Sci USA 85:8998-9002.
14. Ganea D, Sun L (1993): Vasoactive intestinal peptide down-regulates the expression of IL-2 but not of IFN gamma from stimulated murine T lymphocytes. J Neuroimmunol 47:147-158.
15. Hinterberger W, Cerny C, Kinast H, Pointner H, Tragl KH (1978): Somatostatin reduces the release of colony-stimulating activity (CSA) from PHA-activated mouse spleen lymphocytes. Experientia 34:860-862.
16. Hiruma K, Koike T, Nakamura H, Sumida T, Maeda T, Tomioka H, Yoshida S, Fujita T (1990): Somatostatin receptors on human lymphocytes and leukaemia cells. Immunology 71:480-485.
17. Krantic S, Robitaille Y, Quirion R (1992): Deficits in the somatostatin SS1 receptor sub-type in frontal and temporal corticies in Alzheimer's disease. Brain Res 573:299-304.
18. Kubota A, Yamada Y, Kagimoto S, Shimatsu A, Imamura M, Tsuda K, Imura H, Seino S, Seino Y (1994): Identification of somatostatin receptor subtypes and an implication for the efficacity of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors. J Clin Invest 93:1321-1325.
19. Lowry OH, Rosebrough NJ, Farr AL, Randall R (1951): Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275.
20. Manger BA, Weiss A, Weyand C, Gorozny J, Stobo JD (1985): T cell activation: differences in the signals required for IL-2 production by non-activated and activated T cells. J Immunol 135:3669-3674.
21. Mary D, Aussel C, Ferrura B, Fehlmann M (1987): Regulation of interleukin 2 synthesis by cAMP in human T cells. J Immunol 139:1179-1184.
22. McMartin C, Purdon GE (1978): Early fate of somatostatin in the circulation of rat after intravenous injection. J Endocrinol 77:67-74.
23. McPherson GA (1983): A practical computer-based approach to the analysis of radioligand binding experiments. Comput Prog Biomed 17:107-114.
24. Miller GM, Alexander JM, Bikkal HA, Katznelson L, Zervas NT, Klibanski A (1995): Somatostatin receptor subtype gene expression in pituitary adenomas. J Clin Endocrinol Metab 80:1386-1392.
25. Mosman T (1983): Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxic assays. J Immunol Methods 65:55-63.
26. Nio DA, Moylan RN, Roche JK (1993): Modulation of T lymphocyte function by neuropeptides. J Immunol 150: 5281-5288.
27. Nordlind K, Mutt V (1986): Influence of beta-endorphin, somatostatin, substance P and vasoactive intestinal peptide on the proliferative response of human peripheral blood T lymphocytes to mercuric chloride. Int Arch Allergy Appl Immun 80:84-89.
28. Panetta R, Patel YC (1994): Expression of mRNA for all five human somatostatin receptors (hSSTR1-5) in pituitary tumors. Life Sci 56:333-342.
29. Pawlikowski M, Stepien H, Kunert-Radek J, Schally AV (1985): Effect of somatostatin on the proliferation of mouse spleen lymphocytes in vitro. BBRC 129:52-55.
30. Payan DG, Hess CA, Goetzl EJ (1984): Inhibition by somatostatin of the proliferation of T-lymphocytes and Molt-4 lymphoblasts. Cell Immunol 84:433-438.
31. Pérez J, Hoyer D (1995): Co-expression of somatostatin SSTR3 and SSTR4 receptor messenger RNAs in the rat brain. Neuroscience 64:241-253.
32. Postel-Vinay MC, De Mello Coelho V, Gagnerault MC, Dardenne M (1997): Growth Hormone stimulates the proliferation of activated mouse T lymphocytes. Endocrinology 138:1816-1820.
33. Reisine T, Bell GI (1995): Molecular biology of somatostatin receptors. Endocrine Rev 16:427-442.
34. Rohrer L, Raulf F, Bruns C, Buettner R, Hofstaedter F, Schüle R (1993): Cloning and characterization of the fourth human somatostatin receptor. Proc Natl Acad Sci USA 90:4196-4200.
35. Scicchitano R, Dazin P, Bienenstock J, Payan DG, Stanisz AM (1988): The murine IgA-secreting plasmacytoma MOPC-315 expresses somatostatin receptors. J Immunol 141:937-941.
36. Seamon BK, Padgett W, Daly JW (1981): Forskolin: Unique diterpene activator of adenylate cyclase in membranes and in intact cells. Proc Natl Acad Sci USA 78:3363-3367.
37. Sheppard M, Shapiro B, Pimstone B, Kronheim S, Berelowitz M, Gregory M (1979): Metabolic clearance and plasma half-disappearance time of exogenous somatostatin in man. J Clin Endocrinol Metab 48:50-53.
38. Sreedharan SP, Kodama KT, Peterson KE, Goetzl EJ (1989): Distinct subsets of somatostatin receptors on cultured human lymphocytes. J Biol Chem 264:949-952.
39. Stanisz AM, Scicchitano R, Payan DG, Bienenstock J (1987): In vitro studies of immunoregulation by Substance P and somatostatin. Ann NY Acad Sci 496:217-225.
40. Sun L, Ganea D (1993): Vasoactive intestinal peptide inhibits interleukin (IL)-2 and IL-4 production through different molecular mechanisms in T cells activated via the T cell receptor/CD3 complex. J Neuroimmunol 48:59-70.
41. Taniguchi T, Minami Y (1993): The IL-2/IL-2 receptor system: A current overview. Cell 73:5-8.
42. Weiss A, Wiskocil RL, Stobo JD (1984): The role of T3 surface molecules in the activation of human T cells. A two-stimulus requirement for IL-2 production reflects events occurring at a pretranslational level. J Immunol 133:123-128.
43. Xin Z, Tang H, Ganea D (1994): Vasoactive intestinal peptide inhibits interleukin (IL)-2 and IL-4 production in murine thymocytes activated via the TCR/CD3 complex. J Neuroimmunol 54:59-68.